Furthermore, since the synthesis/secretion of adiponectin is at least partly dependent on the accumulation of bioactive lipids, inhibition of the synthesis of these lipids may be a therapeutic strategy in the treatment of metabolic disorders. Here, ADIPOQ is linked to Other metabolic disease.